Min Hui Wang

Acalabrutinib with or without obinutuzumab versus chlorambucil and obinutuzumab for treatment-naive chronic lymphocytic leukaemia (ELEVATE-TN): a randomised, controlled, phase 3 trial

Jeff P. Sharman, Miklós Egyed, Wojciech Jurczak et al. · The Lancet · 2020 · 583 citations · Full text

Hematological Malignancy, Lymphoid Neoplasia, Oncology +8

Human Peptidoglycan Recognition Protein-L Is an N-Acetylmuramoyl-L-alanine Amidase

Zhengming Wang, Xinna Li, Ross Cocklin et al. · Journal of Biological Chemistry · 2003 · 231 citations · Full text

N-acetylmuramoyl-l-alanine Amidase, Biochemistry, Human Pgrp Family +10

Acalabrutinib monotherapy in patients with chronic lymphocytic leukemia who are intolerant to ibrutinib

Farrukh T. Awan, Anna Schuh, Jennifer R. Brown et al. · Blood Advances · 2019 · 181 citations · Full text

Acalabrutinib monotherapy in patients with relapsed/refractory chronic lymphocytic leukemia: updated phase 2 results

John C. Byrd, William G. Wierda, Anna Schuh et al. · Blood · 2019 · 172 citations · Full text

Peptidoglycan recognition proteins kill bacteria by activating protein-sensing two-component systems

Des R. Kashyap, Min Hui Wang, Li-Hui Liu et al. · Nature Medicine · 2011 · 157 citations · Full text

Biochemistry, Natural Sciences, Peptoid +5